Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

6.27
Delayed Data
As of Apr 21
 +0.14 / +2.28%
Today’s Change
5.83
Today|||52-Week Range
11.69
-9.65%
Year-to-Date
Inovio's Ebola Vaccine Positive in Expanded Phase I Study
Apr 12 / Zacks.com - Paid Partner Content